Fig. 2: Distribution of detected pathogens in the examined cohort displayed as percentage (total n = 91).

VZV varicella zoster virus, CMV cytomegalovirus, EBV Epstein–Barr virus, HSV-2 herpes simplex virus 2, HSV-1 herpes simplex virus 1.

VZV varicella zoster virus, CMV cytomegalovirus, EBV Epstein–Barr virus, HSV-2 herpes simplex virus 2, HSV-1 herpes simplex virus 1.